For the Inventor, By the Inventor

Enter assignee name

Hollywood, FL, United States of America

Somerset Therapeutics LLC

USPTO Granted Patents = 43

Trademarks = 2

Forward Citations = 7

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Veerappan Subramanian (41 out of 44 patents)

Ilango Subramanian (41 out of 41 patents)

Mandar V Shah (33 out of 40 patents)

4. Aman Trehan (27 out of 27 patents)

5. Prem Sagar Akasapu (6 out of 6 patents)

6. Rahul Kalhapure (6 out of 6 patents)

7. Ojas Prakashbhai Doshi (5 out of 5 patents)

8. Kumaresan Parthasarathi (4 out of 4 patents)

9. Shambhavi Borde (1 out of 1 patent)

10. Bala Chandran Nayar (1 out of 4 patents)

11. Kathleen Clarence-Smith (1 out of 1 patent)

Core Competencies:

Ascorbic Acid

Ophthalmic Compositions

Glycopeptide Antibiotics

Pilocarpine

Brimonidine

Bimatoprost

Ketorolac

Moxifloxacin

Tobramycin

Triamcinolone

Prednisolone

Levothyroxine

43 patents: Sort by Forward Citations

1. 12714689 - Ready-to-use ascorbic acid compound compositions (2026-08-25),

2. 12708614 - READY-TO-USE ASCORBIC ACID COMPOUND COMPOSITIONS (2026-08-18),

3. 12685720 - Compositions for the effective treatment of vitamin C deficiency-related diseases and other conditions (2026-07-21),

4. 12343373 - Glycopeptide antibiotics liquid formulations and methods and uses thereof (2025-07-01),

5. 12156868 - Formulations of pilocarpine and brimonidine compounds and related methods (2024-12-03),

6. 12128025 - Ready-to-use ascorbic acid compound compositions (2024-10-29),

7. 12102632 - Quinolone dispersions (2024-10-01),

8. 12097178 - Methods of efficiently treating vitamin C deficiency-related diseases and other conditions (2024-09-24),

9. 12064440 - Ophthalmic gel compositions of bimatoprost and timolol and associated methods (2024-08-20),

10. 12042502 - Enhanced penetration ophthalmic compositions of bimatoprost and timolol (2024-07-23),

11. 12029729 - Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof (2024-07-09),

12. 12023315 - Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis (2024-07-02),

13. 12016855 - Prednisolone and moxifloxacin compositions and methods (2024-06-25),

14. 11969410 - Low pH pilocarpine and brimonidine compound formulations and related methods (2024-04-30),

15. 11883382 - Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof (2024-01-30),

Company Overview

Somerset Therapeutics LLC, based in Hollywood, FL, specializes in the development of innovative pharmaceutical solutions, particularly in the realm of glycopeptide antibiotics and ophthalmic compositions. The company focuses on formulating advanced treatments, including pilocarpine and bimatoprost gel, as well as neostigmine and tobramycin conjugates. With a commitment to addressing vitamin C deficiency and enhancing therapeutic efficacy, Somerset Therapeutics is dedicated to improving patient outcomes through its targeted research and development efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

43 Patents

#3 in Hollywood, FL

#187 in Florida

#8,104 in US

#16,047 in the World

Hollywood, FL, United States of America

Somerset Therapeutics LLC

Forward Citations = 7

11 inventors:

Veerappan Subramanian (41 out of 44 patents)

Ilango Subramanian (41 out of 41 patents)

Mandar V Shah (33 out of 40 patents)

4. Aman Trehan (27 out of 27 patents)

5. Prem Sagar Akasapu (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Somerset Therapeutics LLC. Retrieved from https://idiyas.com/company/somerset-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…